How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.

Bristol Myers Squibb offers an attractive 4.5% dividend yield, well above market averages. While the company faces patent expirations on key drugs like Revlimid and Eliquis, its strong financial position, reasonable 72% payout ratio, investment-grade credit rating, and decades-long dividend history suggest the dividend is likely safe for most investors.